<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cunningham, Muriel</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Gilard, Martine</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">ITALIC/ITALICplus: 12-Month Data Suggest 6 Months of DAPT is Noninferior to 24 Months of DAPT</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">11-12</style></pages><abstract><style  face="normal" font="default" size="100%">The Is There a Life for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel trial [ITALIC/ITALICplus] was a large, prospective, open-label randomized trial conducted at 55 sites in Europe and the Middle East, and is discussed in this article. The objective of the trial was to determine if 6 months of dual antiplatelet therapy (DAPT) was noninferior to 24 months of DAPT following DES placement.</style></abstract><number><style face="normal" font="default" size="100%">52</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>